| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2026 ( Subtotal = $111,338,874 ) (Continued on the next page) |
| | 2026 | 2026 | UNIVERSITY OF ALABAMA AT BIRMINGHAM | 701 S 20TH STREET | BIRMINGHAM | AL | 35294-0001 | JEFFERSON | USA | R21NS140497 | Dystrophin as a novel regulator of the circadian clock in skeletal muscle and the brain | 000 | 2 | NIH | 12/5/2025 | $187,316 |
| | 2026 | 2026 | UNIVERSITY OF ALABAMA AT BIRMINGHAM | 701 S 20TH STREET | BIRMINGHAM | AL | 35294-0001 | JEFFERSON | USA | R21NS147535 | AMPA Receptor Function at Interneuron Synapses | 000 | 1 | NIH | 1/15/2026 | $186,250 |
| | 2026 | 2026 | UNIVERSITY OF ALABAMA AT BIRMINGHAM | 701 S 20TH STREET | BIRMINGHAM | AL | 35294-0001 | JEFFERSON | USA | R21MH141410 | Determining the role of localized dopamine signals in learning | 000 | 1 | NIH | 3/6/2026 | $409,750 |
| | 2026 | 2026 | UNIVERSITY OF ALABAMA AT BIRMINGHAM | 701 S 20TH STREET | BIRMINGHAM | AL | 35294-0001 | JEFFERSON | USA | R25CA278711 | The UAB-ENhancing Research In Cancer-related Health professions (ENRICH) Program | 001 | 3 | NIH | 4/16/2026 | $32,400 |
| | 2026 | 2026 | UNIVERSITY OF ALABAMA AT BIRMINGHAM | 701 S 20TH STREET | BIRMINGHAM | AL | 35294-0001 | JEFFERSON | USA | R25CA278711 | The UAB-ENhancing Research In Cancer-related Health professions (ENRICH) Program | 000 | 3 | NIH | 12/17/2025 | $291,600 |
| | 2026 | 2026 | UNIVERSITY OF ALABAMA AT BIRMINGHAM | 701 S 20TH STREET | BIRMINGHAM | AL | 35294-0001 | JEFFERSON | USA | R21CA289166 | Advanced PET/MRI to quantify heterogeneity of HER2 and vasculature in HER2+ breast-to-brain metastasis prior to combination targeted and radiotherapy | 000 | 2 | NIH | 3/5/2026 | $169,583 |
| | 2026 | 2026 | UNIVERSITY OF ALABAMA AT BIRMINGHAM | 701 S 20TH STREET | BIRMINGHAM | AL | 35294-0001 | JEFFERSON | USA | R21CA297395 | Modifying the Single Domain Antibody Framework as Platform for Enhanced Radiotherapy | 001 | 2 | NIH | 4/22/2026 | $17,090 |
| | 2026 | 2026 | UNIVERSITY OF ALABAMA AT BIRMINGHAM | 701 S 20TH STREET | BIRMINGHAM | AL | 35294-0001 | JEFFERSON | USA | R21CA297395 | Modifying the Single Domain Antibody Framework as Platform for Enhanced Radiotherapy | 000 | 2 | NIH | 2/11/2026 | $153,818 |
| | 2026 | 2026 | UNIVERSITY OF ALABAMA AT BIRMINGHAM | 701 S 20TH STREET | BIRMINGHAM | AL | 35294-0001 | JEFFERSON | USA | R21CA296500 | RANK Signaling Inhibitors for Osteolytic Lesions in Multiple Myeloma | 001 | 2 | NIH | 4/17/2026 | $27,513 |
| | 2026 | 2026 | UNIVERSITY OF ALABAMA AT BIRMINGHAM | 701 S 20TH STREET | BIRMINGHAM | AL | 35294-0001 | JEFFERSON | USA | R21CA296500 | RANK Signaling Inhibitors for Osteolytic Lesions in Multiple Myeloma | 000 | 2 | NIH | 1/26/2026 | $247,611 |
| | 2026 | 2026 | UNIVERSITY OF ALABAMA AT BIRMINGHAM | 701 S 20TH STREET | BIRMINGHAM | AL | 35294-0001 | JEFFERSON | USA | R21CA298890 | A Novel Approach to Enhance Therapeutic Efficacy of Tarlatamab for Small Cell Lung Cancer Treatment | 000 | 2 | NIH | 3/27/2026 | $173,559 |
| | 2026 | 2026 | UNIVERSITY OF ALABAMA AT BIRMINGHAM | 701 S 20TH STREET | BIRMINGHAM | AL | 35294-0001 | JEFFERSON | USA | R21EB036277 | Ribozyme-mediated killing of cells harboring cancer driver mutations | 000 | 3 | NIH | 5/11/2026 | $185,172 |
| | 2026 | 2026 | UNIVERSITY OF ALABAMA AT BIRMINGHAM | 701 S 20TH STREET | BIRMINGHAM | AL | 35294-0001 | JEFFERSON | USA | R21ES036166 | Defining molecular target of arsine gas-induced acute kidney injury and associated morbidity | 000 | 2 | NIH | 4/29/2026 | $185,625 |
| | 2026 | 2026 | UNIVERSITY OF ALABAMA AT BIRMINGHAM | 701 S 20TH STREET | BIRMINGHAM | AL | 35294-0001 | JEFFERSON | USA | R21AG092916 | Cocoa to maximize exercise training in older adults - COMET Trial | 001 | 1 | NIH | 4/23/2026 | $0 |
| | 2026 | 2026 | UNIVERSITY OF ALABAMA AT BIRMINGHAM | 701 S 20TH STREET | BIRMINGHAM | AL | 35294-0001 | JEFFERSON | USA | R21AG092916 | Cocoa to maximize exercise training in older adults - COMET Trial | 000 | 1 | NIH | 12/26/2025 | $409,750 |
| | 2026 | 2026 | UNIVERSITY OF ALABAMA AT BIRMINGHAM | 701 S 20TH STREET | BIRMINGHAM | AL | 35294-0001 | JEFFERSON | USA | R21AI187107 | Role of Prp protease in the S. pneumoniae ribosome | 000 | 2 | NIH | 12/9/2025 | $185,625 |
| | 2026 | 2026 | UNIVERSITY OF ALABAMA AT BIRMINGHAM | 701 S 20TH STREET | BIRMINGHAM | AL | 35294-0001 | JEFFERSON | USA | R21AI190764 | Suppression of T-bet+ B cells in lupus by tryptophan metabolites | 000 | 1 | NIH | 2/9/2026 | $409,750 |
| | 2026 | 2026 | UNIVERSITY OF ALABAMA AT BIRMINGHAM | 701 S 20TH STREET | BIRMINGHAM | AL | 35294-0001 | JEFFERSON | USA | R21AI186312 | Novel roles of Fc gamma binding protein in colonic host-microbiota interactions | 000 | 2 | NIH | 4/28/2026 | $185,625 |
| | 2026 | 2026 | UNIVERSITY OF ALABAMA AT BIRMINGHAM | 701 S 20TH STREET | BIRMINGHAM | AL | 35294-0001 | JEFFERSON | USA | R03TR005967 | Molecular and therapeutic correction of XMEA using novel zebrafish and mouse models | 000 | 1 | NIH | 1/28/2026 | $149,000 |
| | 2026 | 2026 | UNIVERSITY OF ALABAMA AT BIRMINGHAM | 701 S 20TH STREET | BIRMINGHAM | AL | 35294-0001 | JEFFERSON | USA | R01NS117698 | Understanding the Etiology of CASK Associated Epileptic Encephalopathy | 001 | 6 | NIH | 3/5/2026 | $37,125 |
| | 2026 | 2026 | UNIVERSITY OF ALABAMA AT BIRMINGHAM | 701 S 20TH STREET | BIRMINGHAM | AL | 35294-0001 | JEFFERSON | USA | R01NS117698 | Understanding the Etiology of CASK Associated Epileptic Encephalopathy | 000 | 6 | NIH | 12/12/2025 | $334,125 |
| | 2026 | 2026 | UNIVERSITY OF ALABAMA AT BIRMINGHAM | 701 S 20TH STREET | BIRMINGHAM | AL | 35294-0001 | JEFFERSON | USA | R01NS126513 | Targeting Transcriptional Elongation in Pediatric Glioma | 000 | 5 | NIH | 3/25/2026 | $360,285 |
| | 2026 | 2026 | UNIVERSITY OF ALABAMA AT BIRMINGHAM | 701 S 20TH STREET | BIRMINGHAM | AL | 35294-0001 | JEFFERSON | USA | T32DK062710 | UAB Obesity Training Program | 002 | 21 | NIH | 4/28/2026 | $1 |
| | 2026 | 2026 | UNIVERSITY OF ALABAMA AT BIRMINGHAM | 701 S 20TH STREET | BIRMINGHAM | AL | 35294-0001 | JEFFERSON | USA | T35DK116670 | Short Term Research Experiences Advancing Medical Students (STREAMS) | 000 | 8 | NIH | 5/12/2026 | $1 |
| | 2026 | 2026 | UNIVERSITY OF ALABAMA AT BIRMINGHAM | 701 S 20TH STREET | BIRMINGHAM | AL | 35294-0001 | JEFFERSON | USA | T32TR004770 | CTSA Postdoctoral T32 at the University of Alabama at Birmingham | 001 | 3 | NIH | 4/23/2026 | $8,683 |
| | 2026 | 2026 | UNIVERSITY OF ALABAMA AT BIRMINGHAM | 701 S 20TH STREET | BIRMINGHAM | AL | 35294-0001 | JEFFERSON | USA | T32TR004770 | CTSA Postdoctoral T32 at the University of Alabama at Birmingham | 000 | 3 | NIH | 3/27/2026 | $439,613 |
| | 2026 | 2026 | UNIVERSITY OF ALABAMA AT BIRMINGHAM | 701 S 20TH STREET | BIRMINGHAM | AL | 35294-0001 | JEFFERSON | USA | T32GM146611 | Training Program in Cell, Molecular, and Developmental Biology | 000 | 3 | NIH | 5/12/2026 | $453,571 |
| | 2026 | 2026 | UNIVERSITY OF ALABAMA AT BIRMINGHAM | 701 S 20TH STREET | BIRMINGHAM | AL | 35294-0001 | JEFFERSON | USA | T32HD071866 | Interdisciplinary Training in Pathobiology and Rehabilitation Medicine. | 001 | 14 | NIH | 4/10/2026 | $296,290 |
| | 2026 | 2026 | UNIVERSITY OF ALABAMA AT BIRMINGHAM | 701 S 20TH STREET | BIRMINGHAM | AL | 35294-0001 | JEFFERSON | USA | R61DA065247 | Remote Fentanyl Test Strip Distribution and Education to Prevent Drug Overdose | 001 | 1 | NIH | 4/10/2026 | $0 |
| | 2026 | 2026 | UNIVERSITY OF ALABAMA AT BIRMINGHAM | 701 S 20TH STREET | BIRMINGHAM | AL | 35294-0001 | JEFFERSON | USA | R61DA065247 | Remote Fentanyl Test Strip Distribution and Education to Prevent Drug Overdose | 000 | 1 | NIH | 3/18/2026 | $447,000 |
| | 2026 | 2026 | UNIVERSITY OF ALABAMA AT BIRMINGHAM | 701 S 20TH STREET | BIRMINGHAM | AL | 35294-0001 | JEFFERSON | USA | RF1MH139795 | Estradiol regulation of an amygdala microcircuit for valence processing | 000 | 2 | NIH | 5/12/2026 | $2,585,531 |
| | 2026 | 2026 | UNIVERSITY OF ALABAMA AT BIRMINGHAM | 701 S 20TH STREET | BIRMINGHAM | AL | 35294-0001 | JEFFERSON | USA | R37AI169864 | Coordination of Innate and Adaptive Immunity in Intestinal Barrier Defense | 000 | 5 | NIH | 3/9/2026 | $567,962 |
| | 2026 | 2026 | UNIVERSITY OF ALABAMA AT BIRMINGHAM | 701 S 20TH STREET | BIRMINGHAM | AL | 35294-0001 | JEFFERSON | USA | R38AI174267 | STIMULATING ACCESS TO INFECTIOUS DISEASES RESEARCH IN RESIDENCY (UAB StARR) | 000 | 3 | NIH | 5/5/2026 | $323,100 |
| | 2026 | 2026 | UNIVERSITY OF ALABAMA AT BIRMINGHAM | 701 S 20TH STREET | BIRMINGHAM | AL | 35294-0001 | JEFFERSON | USA | R37CA296615 | Quality of End-of-Life Care for Children with Cancer: A COG Observational Study | 000 | 2 | NIH | 2/12/2026 | $555,731 |
| | 2026 | 2026 | UNIVERSITY OF ALABAMA AT BIRMINGHAM | 701 S 20TH STREET | BIRMINGHAM | AL | 35294-0001 | JEFFERSON | USA | R37CA296615 | Quality of End-of-Life Care for Children with Cancer: A COG Observational Study | 001 | 2 | NIH | 4/16/2026 | $61,747 |
| | 2026 | 2026 | UNIVERSITY OF ALABAMA AT BIRMINGHAM | 701 S 20TH STREET | BIRMINGHAM | AL | 35294-0001 | JEFFERSON | USA | R35GM156375 | Mechanisms of Molecular Motors in Transcription and Protein Homeostasis | 001 | 2 | NIH | 3/19/2026 | $37,125 |
| | 2026 | 2026 | UNIVERSITY OF ALABAMA AT BIRMINGHAM | 701 S 20TH STREET | BIRMINGHAM | AL | 35294-0001 | JEFFERSON | USA | R35GM156375 | Mechanisms of Molecular Motors in Transcription and Protein Homeostasis | 000 | 2 | NIH | 1/8/2026 | $334,125 |
| | 2026 | 2026 | UNIVERSITY OF ALABAMA AT BIRMINGHAM | 701 S 20TH STREET | BIRMINGHAM | AL | 35294-0001 | JEFFERSON | USA | R35HL166433 | Pathogenic Exosomes in COPD | 000 | 4 | NIH | 4/2/2026 | $1,005,543 |
| | 2026 | 2026 | UNIVERSITY OF ALABAMA AT BIRMINGHAM | 701 S 20TH STREET | BIRMINGHAM | AL | 35294-0001 | JEFFERSON | USA | U01HG014610 | Population Genomic Screening in Primary Care | 000 | 1 | NIH | 4/27/2026 | $831,462 |
| | 2026 | 2026 | UNIVERSITY OF ALABAMA AT BIRMINGHAM | 701 S 20TH STREET | BIRMINGHAM | AL | 35294-0001 | JEFFERSON | USA | U01HG014137 | SouthEast GEnomic Medicine eConsult Service (SE-GEMS) | 001 | 1 | NIH | 5/1/2026 | $0 |
| | 2026 | 2026 | UNIVERSITY OF ALABAMA AT BIRMINGHAM | 701 S 20TH STREET | BIRMINGHAM | AL | 35294-0001 | JEFFERSON | USA | U01HG014137 | SouthEast GEnomic Medicine eConsult Service (SE-GEMS) | 000 | 1 | NIH | 2/27/2026 | $2,912,972 |
| | 2026 | 2026 | UNIVERSITY OF ALABAMA AT BIRMINGHAM | 701 S 20TH STREET | BIRMINGHAM | AL | 35294-0001 | JEFFERSON | USA | U01AI195199 | Congenital Syphilis Treatment Trial (CONSISTENT): Phase IV, Open-label, Randomized Controlled Trial of Amoxicillin vs Benzathine Penicillin in Neonates with Possible Congenital Syphilis | 000 | 1 | NIH | 5/12/2026 | $2,336,069 |
| | 2026 | 2026 | UNIVERSITY OF ALABAMA AT BIRMINGHAM | 701 S 20TH STREET | BIRMINGHAM | AL | 35294-0001 | JEFFERSON | USA | NU62PS924587 | Alabama/North Carolina Regional STD/HIV Prevention Training Center | 05 | 5 | CDC | 3/30/2026 | $100,000 |
| | 2026 | 2026 | UNIVERSITY OF ALABAMA AT BIRMINGHAM | 701 S 20TH STREET | BIRMINGHAM | AL | 35294-0001 | JEFFERSON | USA | UG3NS141843 | Low-dose naltrexone (LDN) for the treatment of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) | 000 | 1 | NIH | 3/6/2026 | $556,686 |
| | 2026 | 2026 | UNIVERSITY OF ALABAMA AT BIRMINGHAM | 701 S 20TH STREET | BIRMINGHAM | AL | 35294-0001 | JEFFERSON | USA | UG3NS145980 | Spinal Cord Neuromodulation Outcomes in Restless Legs Syndrome (NO-RLS) | 000 | 1 | NIH | 4/27/2026 | $644,394 |
| | 2026 | 2026 | UNIVERSITY OF ALABAMA AT BIRMINGHAM | 701 S 20TH STREET | BIRMINGHAM | AL | 35294-0001 | JEFFERSON | USA | UM1AI069452 | A-Z Clinical Trials Unit | 001 | 20 | NIH | 4/22/2026 | $898,975 |
| | 2026 | 2026 | UNIVERSITY OF ALABAMA AT BIRMINGHAM | 701 S 20TH STREET | BIRMINGHAM | AL | 35294-0001 | JEFFERSON | USA | UM1AI069452 | A-Z Clinical Trials Unit | 000 | 20 | NIH | 12/8/2025 | $922,744 |
| | 2026 | 2026 | UNIVERSITY OF ALABAMA AT BIRMINGHAM | 701 S 20TH STREET | BIRMINGHAM | AL | 35294-0001 | JEFFERSON | USA | UH3NS130202 | Stimulus-evoked directional field potentials to guide subthalamic and pallidal DBS for PD | 001 | 3 | NIH | 3/5/2026 | $153,148 |
| | 2026 | 2026 | UNIVERSITY OF ALABAMA AT BIRMINGHAM | 701 S 20TH STREET | BIRMINGHAM | AL | 35294-0001 | JEFFERSON | USA | UH3DE030090 | A Dental implant registry of treatment outcomes of implant therapy by practitioners in the National Dental Practice Based Research Network | 002 | 6 | NIH | 4/22/2026 | $0 |
|
